Stockreport

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis [Yahoo! Finance]

Equillium, Inc.  (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
PDF Thu, February 6, 2025 at 2:00 PM GMT+1 6 min read In This Article BIOCON.NS EQ BIOCON.BO (Graphic: Business Wire) Itolizumab demonstrated clinical efficac [Read more]